immunotherapy
Amfani da Immunotherapy don Magance Ciwon daji na Late-Stage
Introduction Immunotherapy has become a groundbreaking method in cancer treatment, especially for advanced-stage cancer treatments that have demonstrated minimal effectiveness with standard medicines. This innovative appr..
T-Cell CAR, CAR far, immunotherapy, T cell far
Shin CAR T-Cell Ana Samun Farfawar Kwayoyin cuta A Indiya?
Shin kun taɓa tunanin ko akwai wata hanya mai ƙarfi don yaƙi da cutar kansa? Yanzu kawai ka yi tunanin idan wata rana ka sami haske na bege a cikin yaƙin da kake yi da kansa, maganin da ke amfani da ƙarfin garkuwar jikinka don kai hari.
2 saba'in bio, Sin, immunotherapy, JW Therapeutics, Partnership
JW Therapeutics da 2 saba'in bio sun Sanar da Haɗin gwiwar Dabarun don Haɓaka Bincike da Haɓaka Magunguna na tushen T-cell
SHANGHAI, CHINA da CAMBRIDGE, MASSACHUSETTS, US, Oktoba 27, 2022 - JW Therapeutics (HKEX: 2126), wani kamfani mai zaman kansa kuma mai haɓaka fasahar kere kere wanda ke mai da hankali kan haɓakawa, masana'anta, da tallan rigakafin ƙwayoyin cuta.
BMS, Bristol Myers Squibb, immunotherapy, metastatic melanoma, nivolumab da relatlimab, nivolumab da relatlimab-rmbw, Opdualag, USFDA
Farkon LAG-3-Tsarin hanawar rigakafin jiki, Opdualag ™ (nivolumab da relatlimab-rmbw), FDA ta amince da su ga marasa lafiya da ke da melanoma da ba a sake su ba.
Afrilu 2022: Hukumar Kula da Abinci da Magunguna ta Amurka (FDA) ta amince da Opdualag (nivolumab da relatlimab-rmbw), sabon, ƙayyadaddun ƙayyadaddun adadin kashi na farko na nivolumab da relatlimab waɗanda ake gudanarwa azaman jiko guda ɗaya, f..
Babban nauyin tumor, immunotherapy, KEYTRUDA, Pembrolizumab, TMB-H
An yarda da Pembrolizumab don amfani da ita a cikin kowace cutar kansa tare da babban nauyin maye gurbi
Yuli 2021: Hukumar Abinci da Magunguna ta Amurka (FDA) ta faɗaɗa alamun pembrolizumab (Keytruda), maganin rigakafi, don haɗa kowane ciwon daji tare da babban nauyin maye gurbin (TMB-H). Sabuwar izini shine f..
immunotherapy, hanta, Singapore, Jiyya
Singapore ta fara amincewa da rigakafin Injin Injin T cell don cutar kansar hanta
Agusta 19, 2018: Kamfanin fasahar halittu na Singapore Lion TCR Pte. Hukumar Kimiyyar Kiwon Lafiya ta Singapore (HSA) ta amince da Ltd., kuma ana iya amfani da samfurin ɗan takararta (LioCyx ™) don binciken asibiti na kashi na I / II don maganin.
Mota NK, immunotherapy
CAR maganin kashe ƙwayoyin cuta na halitta - MD Anderson abokan haɗin gwiwa tare da Takeda
Jami'ar Texas MD Anderson Cibiyar Ciwon daji da Kamfanin Takeda Pharmaceutical Company Limited sun shiga ingantaccen fahimta da izinin bincike don haɓakawa da kasuwa mai karɓar maganin antigen da ke jagorantar kisa na halitta (CAR.
immunotherapy, Maganin kisa na halitta, NK Cell far
CAR-NK far - Sabuwar rigakafin rigakafi a maganin ciwon daji
CAR-NK far wani sabon nau'i ne na rigakafi a cikin maganin ciwon daji. Immunotherapy ya canza yadda ake magance ciwon daji. Immunotherapy ya kasu kashi biyu: daya shine hana rigakafin rigakafi.
kwayoyi, immunotherapy
Sabuwar maganin rigakafin rigakafin rigakafin cutar kansa
Immune checkpoint inhibitors are a class of drugs that fight with the immune system of the body to fight cancerous cells. However, most patients do not respond to these therapies. There is a newer class of drug that targets two pr..